L-carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: a pilot study
- PMID: 15877203
- DOI: 10.1007/s10545-005-5262-5
L-carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: a pilot study
Abstract
Skeletal muscle function may be impaired in patients with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, but the value of L-carnitine in their long-term management is not clear. This study was designed as a pilot to examine the effects of L-carnitine on exercise tolerance in patients with MCAD deficiency. Four clinically asymoptomatic MCAD-deficient patients, aged 8 to 20 years, were studied. Incremental ramp exercise tests were carried out before and after 4 weeks' treatment with oral L-carnitine (100 mg/kg per day). During exercise without L-carnitine supplementation, plasma carnitine concentrations fell, associated with an increased excretion of urinary acylcarnitines, notably acetylcarnitine, hexanoylcarnitine and octanoylcarnitine. L-carnitine treatment prevented this fall in plasma carnitine and resulted in greater increases in excretion of acylcarnitines. All four patients showed biologically significant improvement in peak oxygen uptake (peak VO2, 18-32% improvement), VO2 at a heart rate of 170 beats/min (15-23% improvement), VO2 at anaerobic threshold (27-42% improvement), and/or oxygen pulse (10-32% improvement). Exercise tolerance in MCAD-deficient patients may be improved by short-term L-carnitine supplementation. This may be the direct result of improved intramitochondrial homeostasis induced by L-carnitine in removing accumulating acyl moieties.
Similar articles
-
Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency.J Inherit Metab Dis. 2006 Oct;29(5):631-6. doi: 10.1007/s10545-006-0355-3. Epub 2006 Aug 2. J Inherit Metab Dis. 2006. PMID: 16972171
-
Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.Pediatr Res. 1992 Jun;31(6):545-51. doi: 10.1203/00006450-199206000-00002. Pediatr Res. 1992. PMID: 1635814
-
Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.Pediatr Res. 1984 Dec;18(12):1325-8. doi: 10.1203/00006450-198412000-00021. Pediatr Res. 1984. PMID: 6441143
-
[Medium-chain acyl-CoA-dehydrogenase (MCAD) deficiency: French consensus for neonatal screening, diagnosis, and management].Arch Pediatr. 2012 Feb;19(2):184-93. doi: 10.1016/j.arcped.2011.10.025. Epub 2012 Jan 12. Arch Pediatr. 2012. PMID: 22244319 French.
-
Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective.J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):370-7. doi: 10.1007/s10545-006-0292-1. J Inherit Metab Dis. 2006. PMID: 16763904 Review.
Cited by
-
A preliminary model of football-related neural stress that integrates metabolomics with transcriptomics and virtual reality.iScience. 2021 Dec 15;25(1):103483. doi: 10.1016/j.isci.2021.103483. eCollection 2022 Jan 21. iScience. 2021. PMID: 35106455 Free PMC article.
-
Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys.Trials. 2017 Dec 19;18(1):603. doi: 10.1186/s13063-017-2327-3. Trials. 2017. PMID: 29258568 Free PMC article.
-
Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency.J Inherit Metab Dis. 2006 Oct;29(5):631-6. doi: 10.1007/s10545-006-0355-3. Epub 2006 Aug 2. J Inherit Metab Dis. 2006. PMID: 16972171
-
Current issues regarding treatment of mitochondrial fatty acid oxidation disorders.J Inherit Metab Dis. 2010 Oct;33(5):555-61. doi: 10.1007/s10545-010-9188-1. Epub 2010 Sep 10. J Inherit Metab Dis. 2010. PMID: 20830526 Review.
-
Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies.Biosci Rep. 2015 Nov 20;36(1):e00281. doi: 10.1042/BSR20150240. Biosci Rep. 2015. PMID: 26589966 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical